On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales...
The NBA season begins next Tuesday, so fantasy basketball draft season is in full swing. Sleepers and busts drive the conversation. Alex Barutha and...